Neuroone Medical Technologies Corp (NMTC) - Total Liabilities

Latest as of March 2026: $2.49 Million USD

Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has total liabilities worth $2.49 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check NMTC financial resilience to evaluate the company's liquid asset resilience ratio.

Neuroone Medical Technologies Corp - Total Liabilities Trend (2010–2025)

This chart illustrates how Neuroone Medical Technologies Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Neuroone Medical Technologies Corp.

Neuroone Medical Technologies Corp Competitors by Total Liabilities

The table below lists competitors of Neuroone Medical Technologies Corp ranked by their total liabilities.

Company	Country	Total Liabilities
AAA Technologies Limited NSE:AAATECH	India	Rs34.38 Million
Kingsrose Mining Ltd AU:KRM	Australia	AU$5.84 Million
G.M. LEATHER S.P.A. F:N78	Germany	€42.22 Million
Sarama Resource V:SWA	Canada	CA$1.78 Million
Holista Colltech Ltd AU:HCT	Australia	AU$6.29 Million
PT Mitra Pack Tbk JK:PTMP	Indonesia	Rp104.19 Billion
The Grob Tea Company Limited NSE:GROBTEA	India	Rs332.49 Million
KYM Holdings Bhd KLSE:8362	Malaysia	RM46.63 Million

Liability Composition Analysis (2010–2025)

This chart breaks down Neuroone Medical Technologies Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See NMTC equity financing ratio to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.37	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.46	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.32	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroone Medical Technologies Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroone Medical Technologies Corp (2010–2025)

The table below shows the annual total liabilities of Neuroone Medical Technologies Corp from 2010 to 2025.

Year	Total Liabilities	Change
2025-09-30	$3.71 Million	-18.36%
2024-09-30	$4.55 Million	+146.11%
2023-09-30	$1.85 Million	-42.58%
2022-09-30	$3.22 Million	+132.43%
2021-09-30	$1.38 Million	-48.60%
2020-09-30	$2.69 Million	+52.16%
2019-09-30	$1.77 Million	-61.64%
2018-09-30	$4.61 Million	+351.02%
2017-09-30	$1.02 Million	+1127.83%
2016-09-30	$83.33K	+134.11%
2015-09-30	$35.59K	+23.14%
2014-09-30	$28.91K	+57.48%
2013-09-30	$18.36K	0.00%
2012-09-30	$18.36K	+7.16%
2011-09-30	$17.13K	+27.33%
2010-09-30	$13.45K	--

About Neuroone Medical Technologies Corp

NASDAQ:NMTC USA Medical Devices

Market Cap

$11.72 Million

Market Cap Rank

#26747 Global

#5559 in USA

Share Price

$1.36

Change (1 day)

-3.55%

52-Week Range

$0.59 - $5.11

All Time High

$26.97